For the overall survival analysis, 100 sufferers in the combination-therapy group and 122 in the vemurafenib group had passed away . The prespecified stopping boundary was crossed, and the analysis was stopped for efficacy on July 14, 2014. A protocol amendment was issued to permit crossover to the combination-therapy group for sufferers assigned to the vemurafenib group, but no patient had crossed over as of the effective data-freezing day of June 27, 2014.With sufficient biological knowledge and the correct techniques, it could even be possible to someday activate these residual beta cells inside individuals to proliferate and produce healthy levels of insulin. Related StoriesInsulin dosage not independent risk element for cardiovascular deathHigher insulin amounts linked to even worse prognosis in advanced breast cancerProduction of insulin determines success rate of weight reduction surgery’We expected to find adult stem cells that differentiate into beta cells,’ stated Kushner. ‘Such adult stem cells are important in renewing epidermis, intestines and other cells.’ ‘However,’ he added, ‘we found no evidence for adult stem cells that provide rise to beta cells or additional pancreatic tissue. We discovered that all beta cells can replicate, and are, in a sense, their own stem cells.’ Kushner’s group discovered that beta cells renew themselves and grow slowly.